CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The seventh annual BioPharm America™ international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place in the center of Boston’s historic Back Bay.
The highly reputable life science partnering event will draw biotech and pharma executives from around the world to identify and enter into strategic relationships that ultimately drive the multibillion dollar drug development industry. The Boston event is uniquely known to draw innovative biotech companies from the region and abroad, as well as pharma and finance companies actively seeking new partners.
The first day features a compelling Keynote and Opening Plenary, followed by a strong program that is sure to drive partnering activity.
A major draw to precede Monday’s Keynote address is the live announcement of the Fierce 15 by John Carroll, Editor-in-Chief of FierceBiotech. The Fierce 15 is a hunt that involves the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven't been done before. The result is fifteen privately held drug developers or platform biotechs with the potential to have a huge impact on the treatment of human diseases. A LIVE Stream announcement of the Fierce 15 will take place during BioPharm America™ 2014 on partnering360:Insight LIVE on September 22, 2014 at 10:45 a.m. EDT.
The Keynote address will be given by Gary Nabel, Chief Scientific Officer at Sanofi, who will also join the Opening Plenary moderated by Karen Bernstein, Co-Founder, Chairman, and Editor-in-Chief at BioCentury on the topic “Getting real: Biopharma innovation and its impact on patients,” with additional panelists Barry Greene, President and COO at Alnylam Pharmaceuticals; Adam M. Koppel, Senior VP and Chief Strategy Officer at Biogen Idec; and Richard Pops, Chairman and CEO at Alkermes plc.
“These are exciting times, because pharma companies are going back to their roots. There’s been a major shift toward external innovation and data-driven science that guides the development of new medicines. For academic research, we see more collaboration at earlier stages. For biotech, we see relationships built at different points in the evolution of new medicines, and we are using structures and support that incentivize both partners to achieve success,” said Nabel.
Global pharmaceutical companies already confirmed to send business development teams to BioPharm America include AstraZeneca; Bayer HealthCare; Bristol-Myers Squibb; EMD Serono; Merck; Novo Nordisk; Sanofi; and Shire.
BioPharm America is produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio) to facilitate strategic collaborations with leading companies. One-to-one networking at BioPharm America™ is powered by partneringONE®, the leading conference networking solution for the life sciences.
Register now to attend the largest dedicated partnering event in the eastern US. Partnering is already open.
To join the conversation:
Visit: BioPharm America™ webpage
Follow: @EBDGroup #BPA14
Talk: Life Science Partnering group
News: partnering360.com/insight
Watch: youtube.com/EBDGROUPChannel
Blog: partnering360.com/blog/
About BioPharm America 2014
BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
Join partnering360® to kick off your partnering activities before BioPharm America, and throughout the year. partnering360 is a dynamic network of life science industry experts that will enable you to continue the dialogue from your partneringONE meetings at events and identify and connect with new partners anytime, year-round.
Notes to Editors:
Entry to BioPharm America 2014 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Members of the media can get registration information on the press registration information page.
An Online Press Kit service for BioPharm America™ 2014 is available to enhance your public relations efforts.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
About MassBio
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.
